Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MetaStat, Inc.MTST.OB · Entity 170270 | Director | April 04, 2017 | April 06, 2017 |
| VYCOR MEDICAL INCVYCO · Entity 8497 | Director | June 30, 2020 | July 08, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MetaStat, Inc.
Report date April 04, 2017 · Filed April 06, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,234 |
Reported balance
After 2017-04-04 transaction · row 1
1 source rowRow 1 · 2017-04-04 · Purchase · Acquired 20,000 · Balance 66,234 F1: Reflects the issuance of 20,000 restricted shares of fully vested common stock approved by the board of directors on April 4, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the issuance of 20,000 restricted shares of fully vested common stock approved by the board of directors on April 4, 2017.
VYCOR MEDICAL INC
Report date June 30, 2020 · Filed July 08, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Vycor Medical Inc. Common Stock Par Value $0.0001SEC Table I · non-derivative | Direct | 506,949 |
Reported balance
After 2020-06-30 transaction · row 1
1 source rowRow 1 · 2020-06-30 · Other · Acquired 33,333 · Balance 506,949 F1: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2020 Filed Jul 8, 2020 01:34 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock Par Value $0.0001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-20-012772 · ownership.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,949 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| March 31, 2020 Filed Apr 7, 2020 10:13 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock Par Value $0.0001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-20-005941 · ownership.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,616 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| December 31, 2019 Filed Jan 7, 2020 11:02 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock Par Value $0.0001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-20-000281 · ownership.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,283 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| September 30, 2019 Filed Oct 9, 2019 18:51 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock Par Value $0.0001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-19-015296 · ownership.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,950 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer, however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:38 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock Par Value $0.0001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-19-010158 · ownership.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,617 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer,however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| March 31, 2019 Filed Apr 3, 2019 19:28 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock Par Value $0.0001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-19-004815 · ownership.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,284 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer,however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| December 31, 2018 Filed Jan 8, 2019 18:43 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc.Common Stock Par Value $0.0001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-19-000302 · ownership.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,951 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deffered compensation plan of the issuer,however the Reporting person has elected to defer reciept of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| September 30, 2018 Filed Oct 23, 2018 13:27 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.0001 | 24,138 | $0.29 | $7,000.02 |
DisclosureSEC source: 0001493152-18-014772 · ownership.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,618 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| June 30, 2018 Filed Jul 10, 2018 10:10 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.0001 | 21,212 | $0.33 | $6,999.96 |
DisclosureSEC source: 0001493152-18-009843 · ownership.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,480 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| March 31, 2018 Filed Apr 4, 2018 17:10 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 14,583 | $0.48 | $6,999.84 |
DisclosureSEC source: 0001493152-18-004739 · form4.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,268 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 17:45 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 18,919 | $0.37 | $7,000.03 |
DisclosureSEC source: 0001493152-18-000080 · form4.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,685 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| September 30, 2017 Filed Oct 6, 2017 19:12 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 25,000 | $0.28 | $7,000.00 |
DisclosureSEC source: 0001493152-17-011378 · form4.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,766 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. F2 · balance_after: Includes a 10,000 share adjustment due to a calculation error on the prior report. Read SEC document |
| June 30, 2017 Filed Jul 21, 2017 19:35 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-17-008077 · form4.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,766 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| April 04, 2017 Filed Apr 6, 2017 20:00 UTC | MetaStat, Inc. MTST.OB · Entity 170270 | PurchaseCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-17-000622 · form4-04062017_080405.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,234 F1 · shares: Reflects the issuance of 20,000 restricted shares of fully vested common stock approved by the board of directors on April 4, 2017. Read SEC document |
| March 31, 2017 Filed Apr 6, 2017 19:59 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 33,333 | $0.21 | $6,999.93 |
DisclosureSEC source: 0001493152-17-003589 · form4.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,433 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| December 31, 2016 Filed Jan 13, 2017 18:45 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 21,212 | $0.33 | $6,999.96 |
DisclosureSEC source: 0001493152-17-000444 · form4.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,100 F1 · shares: Represents a quarterly grant of shares as compensation for services as a director of the issuer pursuant to the Directors' Deferred compensation plan of the Issuer, however, the Reporting person has elected to defer receipt of the shares until January 15th of the year following his termination of services as a director. Read SEC document |
| October 30, 2016 Filed Dec 5, 2016 17:32 UTC | MetaStat, Inc. MTST.OB · Entity 170270 | PurchaseWarrants · Derivative | 7,228 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001415889-16-007524 · form4-12052016_021257.xml · derivative · entry 4 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,228 Underlying: Common Stock · 7,228 shares Expires 2021-10-29 F1 · kind: Effective October 30, 2016, Mr. Bronsther exchanged 5.1189 shares of Series B Preferred Stock plus accrued and unpaid dividends of 754.53 and 2,273 common stock purchase warrants with an exercise price of $10.50 per share into 14,455 shares of common stock and 7,228 common stock purchase warrants with an exercise price of $3.00 per share. F1 · shares: Effective October 30, 2016, Mr. Bronsther exchanged 5.1189 shares of Series B Preferred Stock plus accrued and unpaid dividends of 754.53 and 2,273 common stock purchase warrants with an exercise price of $10.50 per share into 14,455 shares of common stock and 7,228 common stock purchase warrants with an exercise price of $3.00 per share. Read SEC document |
| October 30, 2016 Filed Dec 5, 2016 17:32 UTC | MetaStat, Inc. MTST.OB · Entity 170270 | OtherWarrants · Derivative | 2,273 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001415889-16-007524 · form4-12052016_021257.xml · derivative · entry 3 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,273 shares Expires 2020-03-30 F1 · kind: Effective October 30, 2016, Mr. Bronsther exchanged 5.1189 shares of Series B Preferred Stock plus accrued and unpaid dividends of 754.53 and 2,273 common stock purchase warrants with an exercise price of $10.50 per share into 14,455 shares of common stock and 7,228 common stock purchase warrants with an exercise price of $3.00 per share. F1 · shares: Effective October 30, 2016, Mr. Bronsther exchanged 5.1189 shares of Series B Preferred Stock plus accrued and unpaid dividends of 754.53 and 2,273 common stock purchase warrants with an exercise price of $10.50 per share into 14,455 shares of common stock and 7,228 common stock purchase warrants with an exercise price of $3.00 per share. Read SEC document |
| October 30, 2016 Filed Dec 5, 2016 17:32 UTC | MetaStat, Inc. MTST.OB · Entity 170270 | OtherSeries B Preferred Stock · Derivative | 5.1189 | $2.00 Strike: $2.00 | $10.24 |
DisclosureSEC source: 0001415889-16-007524 · form4-12052016_021257.xml · derivative · entry 2 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 14,455 shares Expires not disclosed F1 · kind: Effective October 30, 2016, Mr. Bronsther exchanged 5.1189 shares of Series B Preferred Stock plus accrued and unpaid dividends of 754.53 and 2,273 common stock purchase warrants with an exercise price of $10.50 per share into 14,455 shares of common stock and 7,228 common stock purchase warrants with an exercise price of $3.00 per share. F1 · shares: Effective October 30, 2016, Mr. Bronsther exchanged 5.1189 shares of Series B Preferred Stock plus accrued and unpaid dividends of 754.53 and 2,273 common stock purchase warrants with an exercise price of $10.50 per share into 14,455 shares of common stock and 7,228 common stock purchase warrants with an exercise price of $3.00 per share. F3 · derivative.expiration_date: The Series B Preferred Stock does not expire. Read SEC document |
| October 30, 2016 Filed Dec 5, 2016 17:32 UTC | MetaStat, Inc. MTST.OB · Entity 170270 | PurchaseCommon Stock | 14,445 | $2.00 | $28,890.00 |
DisclosureSEC source: 0001415889-16-007524 · form4-12052016_021257.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,445 F1 · shares: Effective October 30, 2016, Mr. Bronsther exchanged 5.1189 shares of Series B Preferred Stock plus accrued and unpaid dividends of 754.53 and 2,273 common stock purchase warrants with an exercise price of $10.50 per share into 14,455 shares of common stock and 7,228 common stock purchase warrants with an exercise price of $3.00 per share. F2 · balance_after: Additionally, Mr. Bronsther indirectly beneficially owns 31,779 shares of common stock owned by his spouse. Read SEC document |
| September 30, 2016 Filed Oct 7, 2016 17:54 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherVycor Medical Inc. Common Stock par value $0.001 | 20,588 | $0.34 | $6,999.92 |
DisclosureSEC source: 0001354488-16-008368 · issuerdirect_section16.xml · nonDerivative · entry 1 Bronsther Oscar · CIK 0001543826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,888 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.